ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.240
+0.190 (4.69%)
Mar 4, 2026, 4:00 PM EST - Market closed
ADC Therapeutics Employees
As of December 31, 2024, ADC Therapeutics had 265 total employees, including 263 full-time and 2 part-time employees. The number of employees decreased by 9 or -3.28% compared to the previous year.
Employees
265
Change (1Y)
-9
Growth (1Y)
-3.28%
Revenue / Employee
$283,808
Profits / Employee
-$629,966
Market Cap
525.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | 208 | - | - | 208 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 202 |
| Rigel Pharmaceuticals | 164 |
| Prothena Corporation | 163 |
| Kyverna Therapeutics | 129 |
| Neumora Therapeutics | 95 |
| Lexeo Therapeutics | 61 |
| Tectonic Therapeutic | 60 |
ADCT News
- 1 day ago - ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 - PRNewsWire
- 2 days ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 8 days ago - ADC Therapeutics to Participate in March Investor Conferences - PRNewsWire
- 9 days ago - ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement - PRNewsWire
- 6 weeks ago - ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PRNewsWire
- 7 weeks ago - ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - ADC Therapeutics Announces New Employee Inducement Grant - PRNewsWire